Corporate Disputes is a quarterly e-magazine dedicated to the latest developments in corporate and commercial disputes.
In this issue we present features on mediation versus litigation and on EU trademark reform. We also look at data protection and cyber security litigation; choice of court agreements; reading what the contract doesn’t say; litigation risks and challenges facing the oil & gas industry; managing asbestos claims and litigation; ITC jurisdiction; Swiss attachment law; resolving boardroom disputes; health and safety offences; arbitration in Asia; binding arbitration; cultural considerations when appointing arbitrators; foreign awards in Ukraine; ADR processes; dispute resolution in Scandinavia; ‘multi-step’ dispute resolution clauses; collaborative fairness; investment mediation; disputes in the energy sector; and more.
In this issue we present features on arbitration in the workplace and on Google’s alleged violation of European antitrust laws. We also look at recognition and enforcement of international arbitration awards in Latin America; amicus curiae interventions; lessons from the Raytheon judgments; damages analysis; litigation challenges concerning biosimilars; class actions in the health sector; the Greek 2012 bond haircut; practical lessons for cross-border insolvency; tax disputes and investigations; shareholder’s liability for procedural costs; derivative claims and unfair prejudice petitions; qui tam actions and false claims litigation; nuisance claims; getting the earliest possible settlements; discovery and technology in disputes; and more.
In this issue we present features on changes to arbitration in China and on whistleblowing in the US. We also look at resolving post M&A disputes; US anti-corruption enforcement priorities; the FCPA; cartel damages under the new EU Directive; self-critical privilege; managing product liability; directors and corporate information; controlling transactions; US securities litigation and enforcement; insider trading cases; damages in the pharmaceutical & biotech sector; drafting pharmaceutical patent settlements; ITC section 337; third party litigation funding in Canada; revising institutional arbitration rules; international arbitral awards; UK arbitration; alternative dispute resolution; managing international construction disputes; and more.